Persones / Equip Humà

Alessandra Magnani

Buscador de publicacions

Publicacions

  • Magnani A and Mahlaoui N.

    Managing Inflammatory Manifestations in Patients with Chronic Granulomatous Disease

    PEDIATRIC DRUGS . 18(5): 334-345. Nº de cites: 17

    [doi:10.1007/s40272-016-0182-4]

  • Touzot F, Moshous D, Creidy R, Neven B, Frange P, Cros G, Caccavelli L, Blondeau J, Magnani A, Luby JM, Ternaux B, Picard C, Blanche S, Fischer A, Hacein-Bey-Abina S and Cavazzana M.

    Faster T-cell development following gene therapy compared with haploidentical HSCT in the treatment of SCID-X1

    Blood . 125(23): 3563-3569. Nº de cites: 51

    [doi:10.1182/blood-2014-12-616003]

  • Magnani A, Brosselin P, Beauté J, de Vergnes N, Mouy R, Debré M, Suarez F, Hermine O, Lortholary O, Blanche S, Fischer A and Mahlaoui N.

    Inflammatory manifestations in a single-center cohort of patients with chronic granulomatous disease

    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY . 134(3): 655. Nº de cites: 128

    [doi:10.1016/j.jaci.2014.04.014]

  • Lanzilli G, Traggiai E, Braido F, Garelli V, Folli C, Chiappori A, Riccio AM, Bazurro G, Agazzi A, Magnani A, Canonica GW and Melioli G.

    Administration of a polyvalent mechanical bacterial lysate to elderly patients with COPD: Effects on circulating T, B and NK cells

    IMMUNOLOGY LETTERS . 149(1-2): 62-67. Nº de cites: 21

    [doi:10.1016/j.imlet.2012.11.009]

  • Ravelli A, Varnier GC, Oliveira S, Castell E, Arguedas O, Magnani A, Pistorio A, Ruperto N, Magni-Manzoni S, Galasso R, Lattanzi B, Dalprà S, Battagliese A, Verazza S, Allegra M and Martini A.

    Antinuclear Antibody-Positive Patients Should Be Grouped as a Separate Category in the Classification of Juvenile Idiopathic Arthritis

    ARTHRITIS AND RHEUMATISM . 63(1): 267-275. Nº de cites: 122

    [doi:10.1002/art.30076]

  • Meiorin S, Filocamo G, Pistorio A, Magni-Manzoni S, Sztajnbok F, Cespedes-Cruz A, Magnani A, Ruperto N, Martini A and Ravelli A.

    Impact of involvement of individual joint groups on subdimensions of functional ability scales in juvenile idiopathic arthritis

    CLINICAL AND EXPERIMENTAL RHEUMATOLOGY . 27(3): 527-533. Nº de cites: 6

  • Magnani A, Pistorio A, Magni-Manzoni S, Falcone A, Lombardini G, Bandeira M, Rossi F, Sala I, Martini A and Ravelli A.

    Achievement of a State of Inactive Disease at Least Once in the First 5 Years Predicts Better Outcome of Patients with Polyarticular Juvenile Idiopathic Arthritis

    JOURNAL OF RHEUMATOLOGY . 36(3): 628-634. Nº de cites: 57

    [doi:10.3899/jrheum.080560]

  • Bartoli M, Tarò M, Magni-Manzoni S, Pistorio A, Traverso F, Viola S, Magnani A, Gasparini C, Martini A and Ravelli A.

    The magnitude of early response to methotrexate therapy predicts long-term outcome of patients with juvenile idiopathic arthritis

    ANNALS OF THE RHEUMATIC DISEASES . 67(3): 370-374. Nº de cites: 58

    [doi:10.1136/ard.2007.073445]

  • Felici E, Novarini C, Magni-Manzoni S, Pistorio A, Magnani A, Bozzola E, Buoncompagni A, Martini A and Ravelli A.

    Course of joint disease in patients with antinuclear antibody-positive juvenile idiopathic arthritis

    JOURNAL OF RHEUMATOLOGY . 32(9): 1805-1810. Nº de cites: 35